RHY is also a very good story. It's currently got a market cap of over 280 million dollars.
BD1 has a market cap of around 110 million dollars.
RHY is obviously over valued or BD1 is very much undervalued.
I am thinking that BD1 has a little more left in it.
Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-122
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.005(1.15%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.0¢ | $12.55K | 28.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33459 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 8500 | 1 |
View Market Depth
| Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |